[{"indications": "Indications\u00a0hyperthyroidism", "name": "PROPYLTHIOURACIL", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.2 Thyroid and antithyroid drugs", "6.2.2 Antithyroid drugs", "PROPYLTHIOURACIL"], "cautions": "Cautions\u00a0monitor for hepatotoxicityHepatotoxicity\u00a0Severe hepatic reactions\r\nhave been reported, including fatal cases and cases requiring liver\r\ntransplant\u2014discontinue if significant liver-enzyme abnormalities developCounselling\u00a0Patients should be told\r\nhow to recognise signs of liver disorder and advised to seek prompt\r\nmedical attention if symptoms such as anorexia, nausea, vomiting,\r\nfatigue, abdominal pain, jaundice, dark urine, or pruritus develop", "side-effects": "Side-effects\u00a0see under Carbimazole; leucopenia;\r\nrarely cutaneous vasculitis, thrombocytopenia, aplastic anaemia, hypoprothrombinaemia,\r\nhepatic disorders (including hepatitis, hepatic failure, encephalopathy,\r\nhepatic necrosis; see also Hepatotoxicity above), nephritis, lupus\r\nerythematous-like syndromes", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/202832.htm", "doses": ["See notes above"], "pregnancy": "Pregnancy\u00a0neonatal goitre and hypothyroidism; see also notes above"}]